MedscapeFDA Panel Rejects OTC Use of Montelukast (Singulair Allergy)MedscapeThe Nonprescription Drugs Advisory Committee of the US Food and Drug Administration (FDA) has voted against recommending that montelukast (Singulair Allergy, Merck) be approved as an over-the-counter (OTC) drug for the treatment of allergic rhinitis …FDA Panel Says No to Over-the-Counter Allergy Drug SingulairU.S. News & World ReportFDA Panel Nixes OTC SingulairMedPage TodayFDA rejects bid to sell respiratory drug without prescriptionKPVI News 6The Star-Ledgerall 15 news articles …Read Full Story
FDA Panel Rejects OTC Use of Montelukast (Singulair Allergy) - Medscape
Real Estate of Cebu
